In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma
Fingerprint
Dive into the research topics of 'In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma'. Together they form a unique fingerprint.